Taro Okamoto

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 3

Top Topics

Mesenchymal Stem Cells

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Kohei Kaku, Takashi Kadowaki, Yutaka Seino, Taro Okamoto, Masayoshi Shirakawa, Asako Sato, Edward A O'Neill, Samuel S Engel, Keith D Kaufman
Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin. Diabetes, obesity & metabolism 23 (9) (2021)
Takashi Kadowaki, Yutaka Seino, Kohei Kaku, Taro Okamoto, Miho Kameya, Asako Sato, Tomona Hirano, Nobuyuki Oshima, Ira Gantz, Edward A O'Neill, Samuel S Engel, null null
A randomized, placebo-controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control. Diabetes, obesity & metabolism 23 (6) (2021)
Yutaka Seino, Kohei Kaku, Takashi Kadowaki, Taro Okamoto, Asako Sato, Masayoshi Shirakawa, Edward A O'Neill, Samuel S Engel, Keith D Kaufman
A randomized, placebo-controlled trial to assess the efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes and inadequate glycaemic control on ipragliflozin. Diabetes, obesity & metabolism 23 (6) (2021)